North American Scientific has been named as the exclusive supplier of palladium 103 brachytherapy seeds to Core Oncology for use in the soft tissue brachytherapy market.

Under the terms of the agreement, North American Scientific will also supply its prospera palladium brachytherapy 103 seeds to be distributed by Core Oncology.

The seeds are employed in radiation therapy to combat cancers and are chiefly used against prostate cancer.

Travis Gay, Chief Executive Officer of Core Oncology, said: "We chose North American Scientific because its Prospera seed delivers standardised seed geometries, is in compliance with all industry guidelines and has excellent dose characteristics.

"We also believe that by moving to North American Scientific's products we significantly enhance the quality of our product line, enabling us to serve a larger market.

"Our goal is to provide industry-leading products and services to our clients, and this new partnership illustrates our commitment to this ideal. North American Scientific has a longstanding clinical history and its seeds are accepted as an industry standard."

Source:

North American Scientific Wins New Brachytherapy Contract, 03/10/07
http://biz.yahoo.com/bw/071003/20071003005298.html?.v=1
http://www.coreoncology.com/

Ÿ Adfero Ltd